LOCORTEN Drug Patent Profile
When do Locorten patents expire, and when can generic versions of Locorten launch?
Locorten is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in LOCORTEN is flumethasone pivalate. There is one drug master file entry for this compound. Additional details are available on the flumethasone pivalate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LOCORTEN?
- What are the global sales for LOCORTEN?
- What is Average Wholesale Price for LOCORTEN?
Summary for LOCORTEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 3,306 |
| DailyMed Link: | LOCORTEN at DailyMed |
US Patents and Regulatory Information for LOCORTEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | LOCORTEN | flumethasone pivalate | CREAM;TOPICAL | 016379-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOCORTEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | LOCORTEN | flumethasone pivalate | CREAM;TOPICAL | 016379-001 | Approved Prior to Jan 1, 1982 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOCORTEN
See the table below for patents covering LOCORTEN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Switzerland | 378881 | Verfahren zur Herstellung von Steroidverbindungen | ⤷ Start Trial |
| Germany | 1239307 | Verfahren zur Herstellung therapeutisch wirksamer Steroidverbindungen | ⤷ Start Trial |
| United Kingdom | 902292 | ⤷ Start Trial | |
| United Kingdom | 902293 | ⤷ Start Trial | |
| United Kingdom | 902294 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |

